GlassScriptPhysician profile
Ronney S Shantouf
NPI 1376781419
$4,352.85
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,353.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $3,150.00 | 2019 | |
| Abbott Laboratories | $656.35 | 2019 | |
| Abiomed | $344.83 | 2019 | |
| Medtronic Vascular, INC. | $52.89 | 2019 | |
| Janssen Pharmaceuticals, INC | $46.03 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $30.82 | 2019 | |
| Amgen INC. | $23.46 | 2019 | |
| Lantheus Medical Imaging, INC. | $17.50 | 2019 | |
| Astellas Pharma US INC | $15.77 | 2019 | |
| Irhythm Technologies, INC. | $15.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronney Shantouf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.